Vanda Pharmaceuticals (VNDA)

Add to Watchlists Create an Alert
14.11 +0.11  +0.79% NASDAQ Jul 29, 8:00PM BATS Real time Currency in USD
View Full Chart
VNDA Price Chart
View All Events

VNDA Events

Date Type Description
08/07/2014 10:00 EDT Misc Q2 2014 Vanda Pharmaceuticals Inc. Earnings Conference Call
08/07/2014 Earnings Q2 2014 Vanda Pharmaceuticals Inc. Earnings Results.
05/22/2014 Misc Annual General Meeting for Vanda Pharmaceuticals Inc
05/08/2014 10:00 EDT Misc Vanda Pharmaceuticals Inc 1Q2014 Earning Conference Call
05/08/2014 Earnings Vanda Pharmaceuticals Inc 1Q2014 Earning Result.
02/13/2014 10:00 EDT Misc Vanda Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
02/13/2014 Earnings Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014. Estimate: -0.18.
11/07/2013 10:00 EST Misc Vanda Pharmaceuticals Q3 2013 Conference Call
11/07/2013 Earnings Vanda Pharmaceuticals Q3 2013 Earnings Release. Estimate: -0.37.
07/31/2013 10:00 EDT Misc Second Quarter 2013 Financial Conference Call and Webcast
View All Performance Charts

VNDA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Vanda Pharmaceuticals is up 75.28% over the last year vs S&P 500 Total Return up 19.34%, Celladon up N/A, and Prosensa Holding down 68.02%.

Get Quote for
Advertisement

Portfolio Strategies Featuring VNDA

Did Vanda Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VNDA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.vandapharmaceuticals.com
  • IR Website: http://phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: District of Columbia
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.

VNDA Excel Add-In Codes

  • Name: =YCI("VNDA","name")
  • Description: =YCI("VNDA","description")
  • Sector: =YCI("VNDA","sector")
  • Industry: =YCI("VNDA","industry")
  • Est. Current Fiscal Year End: =YCI("VNDA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.